Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 119 entries
Sorted by: Best Match Show Resources per page
Toward a multifactorial model of expertise: beyond born versus made.

Annals of the New York Academy of Sciences

Hambrick DZ, Burgoyne AP, Macnamara BN, Ullén F.
PMID: 29446457
Ann N Y Acad Sci. 2018 Feb 15; doi: 10.1111/nyas.13586. Epub 2018 Feb 15.

The debate over the origins of individual differences in expertise has raged for over a century in psychology. The "nature" view holds that expertise reflects "innate talent"-that is, genetically determined abilities. The "nurture" view counters that, if talent even...

Cite
Hambrick DZ, Burgoyne AP, Macnamara BN, et al. Toward a multifactorial model of expertise: beyond born versus made. Ann N Y Acad Sci. 2018;doi: 10.1111/nyas.13586.
Hambrick, D. Z., Burgoyne, A. P., Macnamara, B. N., & Ullén, F. (2018). Toward a multifactorial model of expertise: beyond born versus made. Annals of the New York Academy of Sciences, . https://doi.org/10.1111/nyas.13586
Hambrick, David Z, et al. "Toward a multifactorial model of expertise: beyond born versus made." Annals of the New York Academy of Sciences vol. (2018). doi: https://doi.org/10.1111/nyas.13586
Hambrick DZ, Burgoyne AP, Macnamara BN, Ullén F. Toward a multifactorial model of expertise: beyond born versus made. Ann N Y Acad Sci. 2018 Feb 15; doi: 10.1111/nyas.13586. Epub 2018 Feb 15. PMID: 29446457.
Copy Download .nbib Format: NLM
Gastric Plexiform Fibromyxoma.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Banerjee S, de la Torre J, Burgoyne AM, Ponsford Tipps AM, Savides TJ, Sicklick JK.
PMID: 30761468
J Gastrointest Surg. 2019 Sep;23(9):1936-1939. doi: 10.1007/s11605-019-04132-0. Epub 2019 Feb 13.

No abstract available.

Cite
Banerjee S, de la Torre J, Burgoyne AM, et al. Gastric Plexiform Fibromyxoma. J Gastrointest Surg. 2019;23(9):1936-1939doi: 10.1007/s11605-019-04132-0.
Banerjee, S., de la Torre, J., Burgoyne, A. M., Ponsford Tipps, A. M., Savides, T. J., & Sicklick, J. K. (2019). Gastric Plexiform Fibromyxoma. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 23(9), 1936-1939. https://doi.org/10.1007/s11605-019-04132-0
Banerjee, Sudeep, et al. "Gastric Plexiform Fibromyxoma." Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract vol. 23,9 (2019): 1936-1939. doi: https://doi.org/10.1007/s11605-019-04132-0
Banerjee S, de la Torre J, Burgoyne AM, Ponsford Tipps AM, Savides TJ, Sicklick JK. Gastric Plexiform Fibromyxoma. J Gastrointest Surg. 2019 Sep;23(9):1936-1939. doi: 10.1007/s11605-019-04132-0. Epub 2019 Feb 13. PMID: 30761468; PMCID: PMC6692254.
Copy Download .nbib Format: NLM
Mirror Therapy for Phantom Limb Pain at a Pediatric Oncology Institution.

Rehabilitation oncology (American Physical Therapy Association. Oncology Section)

Anghelescu DL, Kelly CN, Steen BD, Wu J, Wu H, DeFeo BM, Scobey K, Burgoyne L.
PMID: 28163987
Rehabil Oncol. 2016 Jul;34(3):104-110.

BACKGROUND AND PURPOSE/OBJECTIVE: Mirror therapy has not been reported for phantom limb pain (PLP) in pediatric oncology. Our aims are to describe the incidence and duration of PLP post-amputation, the duration of follow-up, pain scores and pain medications, and...

Cite
Anghelescu DL, Kelly CN, Steen BD, et al. Mirror Therapy for Phantom Limb Pain at a Pediatric Oncology Institution. Rehabil Oncol. 2016;34(3):104-110
Anghelescu, D. L., Kelly, C. N., Steen, B. D., Wu, J., Wu, H., DeFeo, B. M., Scobey, K., & Burgoyne, L. (2016). Mirror Therapy for Phantom Limb Pain at a Pediatric Oncology Institution. Rehabilitation oncology (American Physical Therapy Association. Oncology Section), 34(3), 104-110.
Anghelescu, Doralina L, et al. "Mirror Therapy for Phantom Limb Pain at a Pediatric Oncology Institution." Rehabilitation oncology (American Physical Therapy Association. Oncology Section) vol. 34,3 (2016): 104-110.
Anghelescu DL, Kelly CN, Steen BD, Wu J, Wu H, DeFeo BM, Scobey K, Burgoyne L. Mirror Therapy for Phantom Limb Pain at a Pediatric Oncology Institution. Rehabil Oncol. 2016 Jul;34(3):104-110. PMID: 28163987; PMCID: PMC5283692.
Copy Download .nbib Format: NLM
The Challenge of Variable Costs in Decisions Based on Cost-Effectiveness Evidence: A Case Study for Brodalumab.

American health & drug benefits

Brixner D, Oderda G, Biskupiak J, Burgoyne DS, Avey SG, Feldman SR.
PMID: 30972150
Am Health Drug Benefits. 2019 Feb;12(1):22-26.

BACKGROUND: Payers often consider cost-effectiveness studies for new drugs when making decisions on coverage, formulary position, and budgets; however, cost-effectiveness studies are often calculated using estimated pricing before a drug's launch. If the drug's price changes on or after...

Cite
Brixner D, Oderda G, Biskupiak J, et al. The Challenge of Variable Costs in Decisions Based on Cost-Effectiveness Evidence: A Case Study for Brodalumab. Am Health Drug Benefits. 2019;12(1):22-26
Brixner, D., Oderda, G., Biskupiak, J., Burgoyne, D. S., Avey, S. G., & Feldman, S. R. (2019). The Challenge of Variable Costs in Decisions Based on Cost-Effectiveness Evidence: A Case Study for Brodalumab. American health & drug benefits, 12(1), 22-26.
Brixner, Diana, et al. "The Challenge of Variable Costs in Decisions Based on Cost-Effectiveness Evidence: A Case Study for Brodalumab." American health & drug benefits vol. 12,1 (2019): 22-26.
Brixner D, Oderda G, Biskupiak J, Burgoyne DS, Avey SG, Feldman SR. The Challenge of Variable Costs in Decisions Based on Cost-Effectiveness Evidence: A Case Study for Brodalumab. Am Health Drug Benefits. 2019 Feb;12(1):22-26. PMID: 30972150; PMCID: PMC6404800.
Copy Download .nbib Format: NLM
Data on numerosity discrimination, inhibition and arithmetic during the early school years.

Data in brief

Malone SA, Pritchard VE, Heron-Delaney M, Burgoyne K, Lervåg A, Hulme C.
PMID: 31205989
Data Brief. 2019 May 25;25:104062. doi: 10.1016/j.dib.2019.104062. eCollection 2019 Aug.

Participants consisted of 496 children (mean age = 6 years; 9 months) recruited from 11 schools in Brisbane, Australia. Children were assessed on the addition and subtraction subtests of the

Cite
Malone SA, Pritchard VE, Heron-Delaney M, et al. Data on numerosity discrimination, inhibition and arithmetic during the early school years. Data Brief. 2019;25:104062doi: 10.1016/j.dib.2019.104062.
Malone, S. A., Pritchard, V. E., Heron-Delaney, M., Burgoyne, K., Lervåg, A., & Hulme, C. (2019). Data on numerosity discrimination, inhibition and arithmetic during the early school years. Data in brief, 25104062. https://doi.org/10.1016/j.dib.2019.104062
Malone, Stephanie A, et al. "Data on numerosity discrimination, inhibition and arithmetic during the early school years." Data in brief vol. 25 (2019): 104062. doi: https://doi.org/10.1016/j.dib.2019.104062
Malone SA, Pritchard VE, Heron-Delaney M, Burgoyne K, Lervåg A, Hulme C. Data on numerosity discrimination, inhibition and arithmetic during the early school years. Data Brief. 2019 May 25;25:104062. doi: 10.1016/j.dib.2019.104062. eCollection 2019 Aug. PMID: 31205989; PMCID: PMC6558229.
Copy Download .nbib Format: NLM
Duodenal-Jejunal Flexure GI Stromal Tumor Frequently Heralds Somatic .

JCO precision oncology

Burgoyne AM, De Siena M, Alkhuziem M, Tang CM, Medina B, Fanta PT, Belinsky MG, von Mehren M, Thorson JA, Madlensky L, Bowler T, D'Angelo F, Stupack DG, Harismendy O, DeMatteo RP, Sicklick JK.
PMID: 29938249
JCO Precis Oncol. 2017;2017. doi: 10.1200/PO.17.00014. Epub 2017 Aug 15.

PURPOSE: GI stromal tumors (GISTs) are commonly associated with somatic mutations in METHODS: We describe the demographic/clinicopathologic features of 177 patients from two institutions whose GISTs underwent next-generation sequencing of ≥315 cancer-related genes.RESULTS: We initially identified six (9.7%) of...

Cite
Burgoyne AM, De Siena M, Alkhuziem M, et al. Duodenal-Jejunal Flexure GI Stromal Tumor Frequently Heralds Somatic . JCO Precis Oncol. 2017;2017doi: 10.1200/PO.17.00014.
Burgoyne, A. M., De Siena, M., Alkhuziem, M., Tang, C. M., Medina, B., Fanta, P. T., Belinsky, M. G., von Mehren, M., Thorson, J. A., Madlensky, L., Bowler, T., D'Angelo, F., Stupack, D. G., Harismendy, O., DeMatteo, R. P., & Sicklick, J. K. (2017). Duodenal-Jejunal Flexure GI Stromal Tumor Frequently Heralds Somatic . JCO precision oncology, 2017. https://doi.org/10.1200/PO.17.00014
Burgoyne, Adam M, et al. "Duodenal-Jejunal Flexure GI Stromal Tumor Frequently Heralds Somatic ." JCO precision oncology vol. 2017 (2017). doi: https://doi.org/10.1200/PO.17.00014
Burgoyne AM, De Siena M, Alkhuziem M, Tang CM, Medina B, Fanta PT, Belinsky MG, von Mehren M, Thorson JA, Madlensky L, Bowler T, D'Angelo F, Stupack DG, Harismendy O, DeMatteo RP, Sicklick JK. Duodenal-Jejunal Flexure GI Stromal Tumor Frequently Heralds Somatic . JCO Precis Oncol. 2017;2017. doi: 10.1200/PO.17.00014. Epub 2017 Aug 15. PMID: 29938249; PMCID: PMC6013064.
Copy Download .nbib Format: NLM
Novel application of vinylpolysiloxane hearing aid impression mold as patient-specific bolus for head and neck cancer radiotherapy.

Clinical case reports

Gunter AE, Burgoyne J, Park M, Kim N, Cao D, Mehta V.
PMID: 32577239
Clin Case Rep. 2020 Mar 23;8(6):944-949. doi: 10.1002/ccr3.2731. eCollection 2020 Jun.

Hearing aid impression material composed of vinylpolysiloxane is an ideal bolus material which may be used to aid in delivery of adjuvant radiation to complex surgical defects of the head and neck. It is affordable, easily accessed, and efficient.

Cite
Gunter AE, Burgoyne J, Park M, et al. Novel application of vinylpolysiloxane hearing aid impression mold as patient-specific bolus for head and neck cancer radiotherapy. Clin Case Rep. 2020;8(6):944-949doi: 10.1002/ccr3.2731.
Gunter, A. E., Burgoyne, J., Park, M., Kim, N., Cao, D., & Mehta, V. (2020). Novel application of vinylpolysiloxane hearing aid impression mold as patient-specific bolus for head and neck cancer radiotherapy. Clinical case reports, 8(6), 944-949. https://doi.org/10.1002/ccr3.2731
Gunter, Anne Elizabeth, et al. "Novel application of vinylpolysiloxane hearing aid impression mold as patient-specific bolus for head and neck cancer radiotherapy." Clinical case reports vol. 8,6 (2020): 944-949. doi: https://doi.org/10.1002/ccr3.2731
Gunter AE, Burgoyne J, Park M, Kim N, Cao D, Mehta V. Novel application of vinylpolysiloxane hearing aid impression mold as patient-specific bolus for head and neck cancer radiotherapy. Clin Case Rep. 2020 Mar 23;8(6):944-949. doi: 10.1002/ccr3.2731. eCollection 2020 Jun. PMID: 32577239; PMCID: PMC7303862.
Copy Download .nbib Format: NLM
Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response.

Clinical cancer research : an official journal of the American Association for Cancer Research

Yebra M, Bhargava S, Kumar A, Burgoyne AM, Tang CM, Yoon H, Banerjee S, Aguilera J, Cordes T, Sheth V, Noh S, Ustoy R, Li S, Advani SJ, Corless CL, Heinrich MC, Kurzrock R, Lippman SM, Fanta PT, Harismendy O, Metallo C, Sicklick JK.
PMID: 34426440
Clin Cancer Res. 2021 Aug 23; doi: 10.1158/1078-0432.CCR-21-2092. Epub 2021 Aug 23.

PURPOSE: Gastrointestinal stromal tumor (GIST) is the most common sarcoma of the gastrointestinal tract, with mutant succinate dehydrogenase (EXPERIMENTAL DESIGN: We describe methods for establishing novel patient-derived RESULTS: Molecular and metabolic characterization of our patient-derived mCONCLUSIONS: We report the...

Cite
Yebra M, Bhargava S, Kumar A, et al. Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response. Clin Cancer Res. 2021;doi: 10.1158/1078-0432.CCR-21-2092.
Yebra, M., Bhargava, S., Kumar, A., Burgoyne, A. M., Tang, C. M., Yoon, H., Banerjee, S., Aguilera, J., Cordes, T., Sheth, V., Noh, S., Ustoy, R., Li, S., Advani, S. J., Corless, C. L., Heinrich, M. C., Kurzrock, R., Lippman, S. M., Fanta, P. T., Harismendy, O., Metallo, C., & Sicklick, J. K. (2021). Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response. Clinical cancer research : an official journal of the American Association for Cancer Research, . https://doi.org/10.1158/1078-0432.CCR-21-2092
Yebra, Mayra, et al. "Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response." Clinical cancer research : an official journal of the American Association for Cancer Research vol. (2021). doi: https://doi.org/10.1158/1078-0432.CCR-21-2092
Yebra M, Bhargava S, Kumar A, Burgoyne AM, Tang CM, Yoon H, Banerjee S, Aguilera J, Cordes T, Sheth V, Noh S, Ustoy R, Li S, Advani SJ, Corless CL, Heinrich MC, Kurzrock R, Lippman SM, Fanta PT, Harismendy O, Metallo C, Sicklick JK. Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response. Clin Cancer Res. 2021 Aug 23; doi: 10.1158/1078-0432.CCR-21-2092. Epub 2021 Aug 23. PMID: 34426440.
Copy Download .nbib Format: NLM
A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity.

Cell discovery

Burgoyne AM, Vann KR, Joshi S, Morales GA, Vega FM, Singh A, Pal D, Merati AB, Kutateladze TG, Durden DL.
PMID: 34315865
Cell Discov. 2020 Jul 28;6(1):49. doi: 10.1038/s41421-020-0181-z.

No abstract available.

Cite
Burgoyne AM, Vann KR, Joshi S, et al. A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity. Cell Discov. 2020;6(1):49doi: 10.1038/s41421-020-0181-z.
Burgoyne, A. M., Vann, K. R., Joshi, S., Morales, G. A., Vega, F. M., Singh, A., Pal, D., Merati, A. B., Kutateladze, T. G., & Durden, D. L. (2020). A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity. Cell discovery, 6(1), 49. https://doi.org/10.1038/s41421-020-0181-z
Burgoyne, Adam M, et al. "A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity." Cell discovery vol. 6,1 (2020): 49. doi: https://doi.org/10.1038/s41421-020-0181-z
Burgoyne AM, Vann KR, Joshi S, Morales GA, Vega FM, Singh A, Pal D, Merati AB, Kutateladze TG, Durden DL. A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity. Cell Discov. 2020 Jul 28;6(1):49. doi: 10.1038/s41421-020-0181-z. PMID: 34315865.
Copy Download .nbib Format: NLM
Talking to Teens about Pain: A Modified Delphi Study of Adolescent Pain Science Education.

Canadian journal of pain = Revue canadienne de la douleur

Leake HB, Heathcote LC, Simons LE, Stinson J, Kamper SJ, Williams CM, Burgoyne LL, Craigie M, Kammers M, Moen D, Pate JW, Szeto K, Moseley GL.
PMID: 35005410
Can J Pain. 2019 Nov 26;3(1):200-208. doi: 10.1080/24740527.2019.1682934. eCollection 2019.

No abstract available.

Cite
Leake HB, Heathcote LC, Simons LE, et al. Talking to Teens about Pain: A Modified Delphi Study of Adolescent Pain Science Education. Can J Pain. 2019;3(1):200-208doi: 10.1080/24740527.2019.1682934.
Leake, H. B., Heathcote, L. C., Simons, L. E., Stinson, J., Kamper, S. J., Williams, C. M., Burgoyne, L. L., Craigie, M., Kammers, M., Moen, D., Pate, J. W., Szeto, K., & Moseley, G. L. (2019). Talking to Teens about Pain: A Modified Delphi Study of Adolescent Pain Science Education. Canadian journal of pain = Revue canadienne de la douleur, 3(1), 200-208. https://doi.org/10.1080/24740527.2019.1682934
Leake, Hayley B, et al. "Talking to Teens about Pain: A Modified Delphi Study of Adolescent Pain Science Education." Canadian journal of pain = Revue canadienne de la douleur vol. 3,1 (2019): 200-208. doi: https://doi.org/10.1080/24740527.2019.1682934
Leake HB, Heathcote LC, Simons LE, Stinson J, Kamper SJ, Williams CM, Burgoyne LL, Craigie M, Kammers M, Moen D, Pate JW, Szeto K, Moseley GL. Talking to Teens about Pain: A Modified Delphi Study of Adolescent Pain Science Education. Can J Pain. 2019 Nov 26;3(1):200-208. doi: 10.1080/24740527.2019.1682934. eCollection 2019. PMID: 35005410; PMCID: PMC8730612.
Copy Download .nbib Format: NLM
Triethyl-ammonium hexa-μ(2)-acetato-κO:O'-diacetato-κO-aqua-μ(3)-oxido-triferrate(III) toluene monosolvate.

Acta crystallographica. Section E, Structure reports online

Burgoyne AR, Meijboom R, Muller A, Omondi BO.
PMID: 22090868
Acta Crystallogr Sect E Struct Rep Online. 2011 Aug 01;67:m1092-3. doi: 10.1107/S160053681102616X. Epub 2011 Jul 13.

The title compound, (C(6)H(16)N)[Fe(3)(CH(3)CO(2))(8)O(H(2)O)]·C(7)H(8), was serendipitously crystallized from a reaction of disilanol with iron(II) acetate. The trinuclear acetatoferrate(III) anion has a triethyl-ammonium cation as the counterion. The three Fe atoms lie on the vertices of a regular triangle and...

Cite
Burgoyne AR, Meijboom R, Muller A, et al. Triethyl-ammonium hexa-μ(2)-acetato-κO:O'-diacetato-κO-aqua-μ(3)-oxido-triferrate(III) toluene monosolvate. Acta Crystallogr Sect E Struct Rep Online. 2011;67:m1092-3doi: 10.1107/S160053681102616X.
Burgoyne, A. R., Meijboom, R., Muller, A., & Omondi, B. O. (2011). Triethyl-ammonium hexa-μ(2)-acetato-κO:O'-diacetato-κO-aqua-μ(3)-oxido-triferrate(III) toluene monosolvate. Acta crystallographica. Section E, Structure reports online, 67m1092-3. https://doi.org/10.1107/S160053681102616X
Burgoyne, Andrew R, et al. "Triethyl-ammonium hexa-μ(2)-acetato-κO:O'-diacetato-κO-aqua-μ(3)-oxido-triferrate(III) toluene monosolvate." Acta crystallographica. Section E, Structure reports online vol. 67 (2011): m1092-3. doi: https://doi.org/10.1107/S160053681102616X
Burgoyne AR, Meijboom R, Muller A, Omondi BO. Triethyl-ammonium hexa-μ(2)-acetato-κO:O'-diacetato-κO-aqua-μ(3)-oxido-triferrate(III) toluene monosolvate. Acta Crystallogr Sect E Struct Rep Online. 2011 Aug 01;67:m1092-3. doi: 10.1107/S160053681102616X. Epub 2011 Jul 13. PMID: 22090868; PMCID: PMC3212166.
Copy Download .nbib Format: NLM
[No title available]

Canadian oncology nursing journal = Revue canadienne de nursing oncologique

Stilos KK, Burgoyne K.
PMID: 34036160
Can Oncol Nurs J. 2021 May 01;31(2):213-220. doi: 10.5737/23688076312213220. eCollection 2021.

No abstract available.

Cite
Stilos KK, Burgoyne K. Intégrer l’écriture réflexive et l’art-thérapie à sa pratique de soins palliatifs. . Can Oncol Nurs J. 2021;31(2):213-220doi: 10.5737/23688076312213220.
Stilos, K. K., & Burgoyne, K. (2021). Intégrer l’écriture réflexive et l’art-thérapie à sa pratique de soins palliatifs. . Canadian oncology nursing journal = Revue canadienne de nursing oncologique, 31(2), 213-220. https://doi.org/10.5737/23688076312213220
Stilos, Kalliopi Kalli, and Burgoyne, Katherine. "Intégrer l’écriture réflexive et l’art-thérapie à sa pratique de soins palliatifs." . Canadian oncology nursing journal = Revue canadienne de nursing oncologique vol. 31,2 (2021): 213-220. doi: https://doi.org/10.5737/23688076312213220
Stilos KK, Burgoyne K. Intégrer l’écriture réflexive et l’art-thérapie à sa pratique de soins palliatifs. . Can Oncol Nurs J. 2021 May 01;31(2):213-220. doi: 10.5737/23688076312213220. eCollection 2021. French. PMID: 34036160; PMCID: PMC8128431.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 119 entries